GlassScriptPhysician profile
Jasmine Gaitor
NPI 1326657974
$1,191.75
in general payments reported to CMS, 2019-2025
11 companies · $927 in 2025
The $927 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $265 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $285.74 | 2024-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $261.41 | 2024-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $159.18 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $157.88 | 2024-2025 | Verquvo |
| Pfizer INC. | $130.91 | 2024-2025 | |
| Novo Nordisk INC | $56.45 | 2025 | Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $43.12 | 2024 | |
| Amgen INC. | $39.00 | 2024-2025 | Repatha, Repatha |
| Irhythm Technologies, INC. | $38.79 | 2024 | Zio Monitor, Zio Xt Patch |
| Philips North America LLC | $13.58 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Altathera Pharmaceuticals LLC | $5.69 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Gaitor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.